{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:48:20Z","timestamp":1772783300553,"version":"3.50.1"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,4,8]],"date-time":"2018-04-08T00:00:00Z","timestamp":1523145600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Mater."],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s40843-018-9244-5","type":"journal-article","created":{"date-parts":[[2018,4,14]],"date-time":"2018-04-14T02:36:29Z","timestamp":1523673389000},"page":"1367-1386","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Recent therapeutic applications of the theranostic principle with dendrimers in oncology","\u6811\u72b6\u5927\u5206\u5b50\u7528\u4e8e\u80bf\u7624\u8bca\u7597\u539f\u5219\u7684\u6700\u65b0\u6cbb\u7597\u5e94\u7528"],"prefix":"10.1007","volume":"61","author":[{"given":"Serge","family":"Mignani","sequence":"first","affiliation":[]},{"given":"Joao","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Helena","family":"Tomas","sequence":"additional","affiliation":[]},{"given":"Anne-Marie","family":"Caminade","sequence":"additional","affiliation":[]},{"given":"R\u00e9gis","family":"Laurent","sequence":"additional","affiliation":[]},{"given":"Xiangyang","family":"Shi","sequence":"additional","affiliation":[]},{"given":"Jean-Pierre","family":"Majoral","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,4,8]]},"reference":[{"key":"9244_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrc1566","volume":"5","author":"M Ferrari","year":"2005","unstructured":"Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer, 2005, 5: 161\u2013171","journal-title":"Nat Rev Cancer"},{"key":"9244_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nrd1632","volume":"4","author":"VP Torchilin","year":"2005","unstructured":"Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov, 2005, 4: 145\u2013160","journal-title":"Nat Rev Drug Discov"},{"key":"9244_CR3","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.tips.2009.08.004","volume":"30","author":"Y Malam","year":"2009","unstructured":"Malam Y, Loizidou M, Seifalian AM. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacological Sci, 2009, 30: 592\u2013599","journal-title":"Trends Pharmacological Sci"},{"key":"9244_CR4","doi-asserted-by":"publisher","first-page":"0063","DOI":"10.1038\/s41570-017-0063","volume":"1","author":"A Kakkar","year":"2017","unstructured":"Kakkar A, Traverso G, Farokhzad OC, et al. Evolution of macromolecular complexity in drug delivery systems. Nat Rev Chem, 2017, 1: 0063","journal-title":"Nat Rev Chem"},{"key":"9244_CR5","first-page":"44","volume":"4","author":"T Baig","year":"2015","unstructured":"Baig, T, Nayak J, Dwivedi V, et al. A review about dendrimers: Synthesis, types, characterization and applications. IJAPBC, 2015, 4: 44\u201359","journal-title":"IJAPBC"},{"key":"9244_CR6","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1021\/cr900327d","volume":"110","author":"D Astruc","year":"2010","unstructured":"Astruc D, Boisselier E, Ornelas C. Dendrimers designed for functions: from physical, photophysical, and supramolecular properties to applications in sensing, catalysis, molecular electronics, photonics, and nanomedicine. Chem Rev, 2010, 110: 1857\u20131959","journal-title":"Chem Rev"},{"key":"9244_CR7","volume-title":"Chapter 4. Types of dendrimers and their synthesis. In: Dendrimer Chemistry: Concepts","author":"F Vogtle","year":"2009","unstructured":"Vogtle F, Richard G, Werner N. Chapter 4. Types of dendrimers and their synthesis. In: Dendrimer Chemistry: Concepts, Syntheses, Properties, Applications, Wiley-VCH Verlag, 2009"},{"key":"9244_CR8","first-page":"561","volume":"2","author":"R Rupp","year":"2007","unstructured":"Rupp R, Rosenthal, SL, Stanberry LR. VivaGel\u2122 (SPL7013 Gel): a candidate dendrimer-microbicide for the prevention of HIV and HSV infection. Int J Nanomedicine, 2007, 2: 561\u2013566","journal-title":"Int J Nanomedicine"},{"key":"9244_CR9","unstructured":"Starpharma, Available at http:\/\/www.starpharma.com"},{"key":"9244_CR10","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.addr.2010.08.004","volume":"62","author":"SM Janib","year":"2010","unstructured":"Janib SM, Moses AS, MacKay JA. Imaging and drug delivery using theranostic nanoparticles. Adv Drug Deliver Rev, 2010, 62: 1052\u20131063","journal-title":"Adv Drug Deliver Rev"},{"key":"9244_CR11","doi-asserted-by":"publisher","first-page":"930","DOI":"10.7150\/thno.14855","volume":"6","author":"Y Ma","year":"2016","unstructured":"Ma Y, Mou Q, Wang D, et al. Dendritic polymers for theranostics. Theranostics, 2016, 6: 930\u2013947","journal-title":"Theranostics"},{"key":"9244_CR12","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.1016\/j.biomaterials.2012.03.084","volume":"33","author":"Y Liu","year":"2012","unstructured":"Liu Y, Zhang N. Gadolinium loaded nanoparticles in theranostic magnetic resonance imaging. Biomaterials, 2012, 33: 5363\u20135375","journal-title":"Biomaterials"},{"key":"9244_CR13","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ejpb.2015.06.023","volume":"97","author":"B Nottelet","year":"2015","unstructured":"Nottelet B, Darcos V, Coudane J. Aliphatic polyesters for medical imaging and theranostic applications. Eur J Pharm Biopharm, 2015, 97: 350\u2013370","journal-title":"Eur J Pharm Biopharm"},{"key":"9244_CR14","volume-title":"WIREs Nanomed Nanobiotechnol","author":"MT McMahon","year":"2017","unstructured":"McMahon MT, Bulte JWM. Two decades of dendrimers as versatile MRI agents: a tale with and without metals. WIREs Nanomed Nanobiotechnol, 2017, 2: e1496"},{"key":"9244_CR15","doi-asserted-by":"publisher","first-page":"11467","DOI":"10.1021\/ja803036e","volume":"130","author":"S Dhar","year":"2008","unstructured":"Dhar S, Liu Z, Thomale J, et al. Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device. J Am Chem Soc, 2008, 130: 11467\u201311476","journal-title":"J Am Chem Soc"},{"key":"9244_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.addr.2009.11.027","volume":"62","author":"DB Pike","year":"2010","unstructured":"Pike DB, Ghandehari H. HPMA copolymer\u2013cyclic RGD conjugates for tumor targeting. Adv Drug Deliver Rev, 2010, 62: 167\u2013183","journal-title":"Adv Drug Deliver Rev"},{"key":"9244_CR17","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.2147\/IJN.S32804","volume":"7","author":"X Gao","year":"2012","unstructured":"Gao X, Luo Y, Wang Y, et al. Prostate stem cell antigen-targeted nanoparticles with dual functional properties: in vivo imaging and cancer chemotherapy. IJN, 2012, 7: 4037\u20134051","journal-title":"IJN"},{"key":"9244_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.addr.2009.11.029","volume":"62","author":"M Talelli","year":"2010","unstructured":"Talelli M, Rijcken CJF, van Nostrum CF, et al. Micelles based on HPMA copolymers. Adv Drug Deliver Rev, 2010, 62: 231\u2013239","journal-title":"Adv Drug Deliver Rev"},{"key":"9244_CR19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ejpb.2008.09.025","volume":"71","author":"DA Christian","year":"2009","unstructured":"Christian DA, Cai S, Bowen DM, et al. Polymersome carriers: From self-assembly to siRNA and protein therapeutics. Eur J Pharm Biopharm, 2009, 71: 463\u2013474","journal-title":"Eur J Pharm Biopharm"},{"key":"9244_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.addr.2009.03.007","volume":"61","author":"VI Shubayev","year":"2009","unstructured":"Shubayev VI, Pisanic Ii TR, Jin S. Magnetic nanoparticles for theragnostics. Adv Drug Deliver Rev, 2009, 61: 467\u2013477","journal-title":"Adv Drug Deliver Rev"},{"key":"9244_CR21","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ultras.2007.11.002","volume":"48","author":"Z Gao","year":"2008","unstructured":"Gao Z, Kennedy AM, Christensen DA, et al. Drug-loaded nano\/microbubbles for combining ultrasonography and targeted chemotherapy. Ultrasonics, 2008, 48: 260\u2013270","journal-title":"Ultrasonics"},{"key":"9244_CR22","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.bmcl.2009.11.065","volume":"20","author":"TP Thomas","year":"2010","unstructured":"Thomas TP, Shukla R, Kotlyar A, et al. Dendrimer-based tumor cell targeting of fibroblast growth factor-1. Bioorg Medicinal Chem Lett, 2010, 20: 700\u2013703","journal-title":"Bioorg Medicinal Chem Lett"},{"key":"9244_CR23","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1039\/b927215c","volume":"46","author":"S Ki Choi","year":"2010","unstructured":"Ki Choi S, Thomas T, Li MH, et al. Light-controlled release of caged doxorubicin from folate receptor-targeting PAMAM dendrimer nanoconjugate. Chem Commun, 2010, 46: 2632\u20132634","journal-title":"Chem Commun"},{"key":"9244_CR24","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1021\/bc800125u","volume":"19","author":"P Singh","year":"2008","unstructured":"Singh P, Gupta U, Asthana A, et al. Folate and Folate\u2212PEG\u2212PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice. Bioconjugate Chem, 2008, 19: 2239\u20132252","journal-title":"Bioconjugate Chem"},{"key":"9244_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jcis.2010.05.035","volume":"350","author":"Y Zhao","year":"2010","unstructured":"Zhao Y, Liu S, Li Y, et al. Synthesis and grafting of folate\u2013PEG\u2013PAMAM conjugates onto quantum dots for selective targeting of folate-receptor-positive tumor cells. J Colloid Interface Sci, 2010, 350: 44\u201350","journal-title":"J Colloid Interface Sci"},{"key":"9244_CR26","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.7150\/thno.15081","volume":"6","author":"Y Li","year":"2016","unstructured":"Li Y, Li Y, Zhang X, et al. Supramolecular PEGylated dendritic systems as pH\/redox dual-responsive theranostic nanoplatforms for platinum drug delivery and NIR imaging. Theranostics, 2016, 6: 1293\u20131305","journal-title":"Theranostics"},{"key":"9244_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mrm.1910310102","volume":"31","author":"E Wiener","year":"1994","unstructured":"Wiener E, Brechbiel MW, Brothers H, et al. Dendrimer-based metal chelates: A new class of magnetic resonance imaging contrast agents. Magn Reson Med, 1994, 31: 1\u20138","journal-title":"Magn Reson Med"},{"key":"9244_CR28","doi-asserted-by":"publisher","first-page":"14507","DOI":"10.1002\/chem.201403883","volume":"20","author":"J Zhu","year":"2014","unstructured":"Zhu J, Gale EM, Atanasova I, et al. Hexameric MnII dendrimer as MRI contrast agent. Chem Eur J, 2014, 20: 14507\u201314513","journal-title":"Chem Eur J"},{"key":"9244_CR29","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/jmri.21969","volume":"30","author":"S Aime","year":"2009","unstructured":"Aime S, Caravan P. Biodistribution of gadolinium-based contrast agents, including gadolinium deposition. J Magn Reson Imag, 2009, 30: 1259\u20131267","journal-title":"J Magn Reson Imag"},{"key":"9244_CR30","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1148\/radiol.2015150805","volume":"275","author":"E Kanal","year":"2015","unstructured":"Kanal E, Tweedle MF. Residual or retained gadolinium: practical implications for radiologists and our patients. Radiology, 2015, 275: 630\u2013634","journal-title":"Radiology"},{"key":"9244_CR31","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/mrm.10106","volume":"47","author":"S Aime","year":"2002","unstructured":"Aime S, Barge A, Delli Castelli D, et al. Paramagnetic Lanthanide (III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications. Magn Reson Med, 2002, 47: 639\u2013648","journal-title":"Magn Reson Med"},{"key":"9244_CR32","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1021\/ja005820q","volume":"123","author":"S Zhang","year":"2001","unstructured":"Zhang S, Winter P, Wu K, et al. A novel europium(III)-based MRI contrast agent. J Am Chem Soc, 2001, 123: 1517\u20131518","journal-title":"J Am Chem Soc"},{"key":"9244_CR33","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/nbm.1570","volume":"24","author":"J Ruiz-Cabello","year":"2011","unstructured":"Ruiz-Cabello J, Barnett BP, Bottomley PA, et al. Fluorine (19F) MRS and MRI in biomedicine. NMR Biomed, 2011, 24: 114\u2013129","journal-title":"NMR Biomed"},{"key":"9244_CR34","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3181\/0702-RM-33","volume":"232","author":"R Xu","year":"2007","unstructured":"Xu R, Wang Y, Wang X, et al. In vivo evaluation of a PAMAMcystamine-( Gd-DO3A) conjugate as a biodegradable macromolecular MRI contrast agent. Exp Biol Med (Maywood), 2007, 232: 1081\u20131089","journal-title":"Exp Biol Med (Maywood)"},{"key":"9244_CR35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/cmmi.483","volume":"7","author":"PJ Klemm","year":"2012","unstructured":"Klemm PJ, Floyd Iii WC, Smiles DE, et al. Improving T1 and T2 magnetic resonance imaging contrast agents through the conjugation of an esteramide dendrimer to high-water-coordination Gd(III) hydroxypyridinone complexes. Contrast Media Mol Imag, 2012, 7: 95\u201399","journal-title":"Contrast Media Mol Imag"},{"key":"9244_CR36","doi-asserted-by":"publisher","first-page":"14369","DOI":"10.1039\/c2jm32211k","volume":"22","author":"M Ye","year":"2012","unstructured":"Ye M, Qian Y, Shen Y, et al. Facile synthesis and in vivo evaluation of biodegradable dendritic MRI contrast agents. J Mater Chem, 2012, 22: 14369\u201314377","journal-title":"J Mater Chem"},{"key":"9244_CR37","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jconrel.2013.01.034","volume":"169","author":"M Ye","year":"2013","unstructured":"Ye M, Qian Y, Tang J, et al. Targeted biodegradable dendritic MRI contrast agent for enhanced tumor imaging. J Control Release, 2013, 169: 239\u2013245","journal-title":"J Control Release"},{"key":"9244_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/cjoc.201300889","volume":"32","author":"T Li","year":"2014","unstructured":"Li T, Qian Y, Ye M, et al. Synthesis and properties of a biodegradable dendritic magnetic resonance imaging contrast agent. Chin J Chem, 2014, 32: 91\u201396","journal-title":"Chin J Chem"},{"key":"9244_CR39","first-page":"104","volume":"12","author":"SD Konda","year":"2001","unstructured":"Konda SD, Aref M, Wang S, et al. Specific targeting of folatedendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts. Magna, 2001, 12: 104\u2013113","journal-title":"Magna"},{"key":"9244_CR40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1517\/17425247.4.2.149","volume":"4","author":"AM Mohs","year":"2007","unstructured":"Mohs AM, Lu ZR. Gadolinium(III)-based blood-pool contrast agents for magnetic resonance imaging: status and clinical potential. Expert Opin Drug Deliver, 2007, 4: 149\u2013164","journal-title":"Expert Opin Drug Deliver"},{"key":"9244_CR41","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1021\/bm800486c","volume":"9","author":"TL Kaneshiro","year":"2008","unstructured":"Kaneshiro TL, Jeong EK, Morrell G, et al. Synthesis and evaluation of globular Gd-DOTA-monoamide conjugates with precisely controlled nanosizes for magnetic resonance angiography. Biomacromolecules, 2008, 9: 2742\u20132748","journal-title":"Biomacromolecules"},{"key":"9244_CR42","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/jmri.21245","volume":"27","author":"CC Cyran","year":"2008","unstructured":"Cyran CC, Fu Y, Raatschen HJ, et al. New macromolecular polymeric MRI contrast agents for application in the differentiation of cancer from benign soft tissues. J Magn Reson Imag, 2008, 27: 581\u2013589","journal-title":"J Magn Reson Imag"},{"key":"9244_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jconrel.2017.01.010","volume":"248","author":"M Filippi","year":"2017","unstructured":"Filippi M, Catanzaro V, Patrucco D, et al. First in vivo MRI study on theranostic dendrimersomes. J Control Release, 2017, 248: 45\u201352","journal-title":"J Control Release"},{"key":"9244_CR44","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.1016\/j.biomaterials.2009.04.014","volume":"30","author":"JM Criscione","year":"2009","unstructured":"Criscione JM, Le BL, Stern E, et al. Self-assembly of pH-responsive fluorinated dendrimer-based particulates for drug delivery and noninvasive imaging. Biomaterials, 2009, 30: 3946\u20133955","journal-title":"Biomaterials"},{"key":"9244_CR45","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1021\/acs.biomac.6b01885","volume":"18","author":"D Luong","year":"2017","unstructured":"Luong D, Sau S, Kesharwani P, et al. Polyvalent folate-dendrimercoated iron oxide theranostic nanoparticles for simultaneous magnetic resonance imaging and precise cancer cell targeting. Biomacromolecules, 2017, 18: 1197\u20131209","journal-title":"Biomacromolecules"},{"key":"9244_CR46","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1073\/pnas.0811757106","volume":"106","author":"A Almutairi","year":"2009","unstructured":"Almutairi A, Rossin R, Shokeen M, et al. Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis. Proc Natl Acad Sci USA, 2009, 106: 685\u2013690","journal-title":"Proc Natl Acad Sci USA"},{"key":"9244_CR47","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1039\/b615940k","volume":"5","author":"I Dijkgraaf","year":"2007","unstructured":"Dijkgraaf I, Rijnders AY, Soede A, et al. Synthesis of DOTAconjugated multivalent cyclic-RGD peptide dendrimers via 1,3-dipolar cycloaddition and their biological evaluation: implications for tumor targeting and tumor imaging purposes. Org Biomol Chem, 2007, 5: 935\u2013944","journal-title":"Org Biomol Chem"},{"key":"9244_CR48","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1007\/s002590000293","volume":"27","author":"H Kobayashi","year":"2000","unstructured":"Kobayashi H, Sato N, Saga T, et al. Monoclonal antibody-dendrimer conjugates enable radiolabeling of antibody with markedly high specific activity with minimal loss of immunoreactivity. Eur J Nucl Med, 2000, 27: 1334\u20131339","journal-title":"Eur J Nucl Med"},{"key":"9244_CR49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1021\/bc980091d","volume":"10","author":"H Kobayashi","year":"1999","unstructured":"Kobayashi H, Wu C, Kim MK, et al. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-tac monoclonal antibody. Bioconjugate Chem, 1999, 10: 103\u2013111","journal-title":"Bioconjugate Chem"},{"key":"9244_CR50","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s10118-013-1242-7","volume":"3","author":"N Li","year":"2013","unstructured":"Li N, Jin Y, Xue LZ, et al. 188Re-Labeled hyperbranched polysulfonamine as a robust tool for targeted cancer diagnosis and radioimmunotherapy. Chin J Polym Sci, 2013, 3: 530\u2013540","journal-title":"Chin J Polym Sci"},{"key":"9244_CR51","doi-asserted-by":"publisher","first-page":"18169","DOI":"10.1039\/C5NR05585G","volume":"7","author":"J Zhu","year":"2015","unstructured":"Zhu J, Zhao L, Cheng Y, et al. Radionuclide 131I-labeled multifunctional dendrimers for targeted SPECT imaging and radiotherapy of tumors. Nanoscale, 2015, 7: 18169\u201318178","journal-title":"Nanoscale"},{"key":"9244_CR52","doi-asserted-by":"publisher","first-page":"19798","DOI":"10.1021\/acsami.5b05836","volume":"7","author":"L Zhao","year":"2015","unstructured":"Zhao L, Zhu J, Cheng Y, et al. Chlorotoxin-conjugated multifunctional dendrimers labeled with radionuclide 131I for single photon emission computed tomography imaging and radiotherapy of gliomas. ACS Appl Mater Interfaces, 2015, 7: 19798\u201319808","journal-title":"ACS Appl Mater Interfaces"},{"key":"9244_CR53","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.2967\/jnumed.112.115493","volume":"54","author":"GK Gr\u00fcnwald","year":"2013","unstructured":"Gr\u00fcnwald GK, Vetter A, Klutz K, et al. Systemic image-guided liver cancer radiovirotherapy using dendrimer-coated adenovirus encoding the sodium iodide symporter as theranostic gene. J Nucl Med, 2013, 54: 1450\u20131457","journal-title":"J Nucl Med"},{"key":"9244_CR54","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1021\/nl020246x","volume":"2","author":"AT Yordanov","year":"2002","unstructured":"Yordanov AT, Lodder AL, Woller EK, et al. Novel iodinated dendritic nanoparticles for computed tomography (CT) imaging. Nano Lett, 2002, 2: 595\u2013599","journal-title":"Nano Lett"},{"key":"9244_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/1039258","volume":"2016","author":"H Mendoza-Nava","year":"2016","unstructured":"Mendoza-Nava H, Ferro-Flores G, Ram\u00edrez FM, et al. 177Lu-dendrimer conjugated to folate and bombesin with gold nanoparticles in the dendritic cavity: a potential theranostic radiopharmaceutical. J Nanomaterials, 2016, 2016: 1\u201311","journal-title":"J Nanomaterials"},{"key":"9244_CR56","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.2174\/138920012802850010","volume":"13","author":"R Guo","year":"2012","unstructured":"Guo R, Shi X. Dendrimers in cancer therapeutics and diagnosis. CDM, 2012, 13: 1097\u20131109","journal-title":"CDM"},{"key":"9244_CR57","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/wnan.1331","volume":"7","author":"D Li","year":"2015","unstructured":"Li D, Wen S, Shi X. Dendrimer-entrapped metal colloids as imaging agents. WIREs Nanomed Nanobiotechnol, 2015, 7: 678\u2013690","journal-title":"WIREs Nanomed Nanobiotechnol"},{"key":"9244_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.progpolymsci.2014.08.002","volume":"44","author":"Z Qiao","year":"2015","unstructured":"Qiao Z, Shi X. Dendrimer-based molecular imaging contrast agents. Prog Polymer Sci, 2015, 44: 1\u201327","journal-title":"Prog Polymer Sci"},{"key":"9244_CR59","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1002\/app.32845","volume":"119","author":"C Peng","year":"2011","unstructured":"Peng C, Wang H, Guo R, et al. Acetylation of dendrimer-entrapped gold nanoparticles: Synthesis, stability, and X-ray attenuation properties. J Appl Polym Sci, 2011, 119: 1673\u20131682","journal-title":"J Appl Polym Sci"},{"key":"9244_CR60","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1016\/j.biomaterials.2011.01.001","volume":"32","author":"H Wang","year":"2011","unstructured":"Wang H, Zheng L, Peng C, et al. Computed tomography imaging of cancer cells using acetylated dendrimer-entrapped gold nanoparticles. Biomaterials, 2011, 32: 2979\u20132988","journal-title":"Biomaterials"},{"key":"9244_CR61","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.biomaterials.2012.09.054","volume":"34","author":"H Wang","year":"2013","unstructured":"Wang H, Zheng L, Peng C, et al. Folic acid-modified dendrimerentrapped gold nanoparticles as nanoprobes for targeted CT imaging of human lung adencarcinoma. Biomaterials, 2013, 34: 470\u2013480","journal-title":"Biomaterials"},{"key":"9244_CR62","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1364\/OL.35.001088","volume":"35","author":"C Vinegoni","year":"2010","unstructured":"Vinegoni C, Feruglio PF, Cortez-Retamozo V, et al. Imaging of molecular probe activity with Born-normalized fluorescence optical projection tomography. Opt Lett, 2010, 35: 1088\u20131090","journal-title":"Opt Lett"},{"key":"9244_CR63","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/smll.200801375","volume":"5","author":"R Guo","year":"2009","unstructured":"Guo R, Li R, Li X, et al. Dual-functional alginic acid hybrid nanospheres for cell imaging and drug delivery. Small, 2009, 5: 709\u2013717","journal-title":"Small"},{"key":"9244_CR64","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/smll.200400093","volume":"1","author":"EE Connor","year":"2005","unstructured":"Connor EE, Mwamuka J, Gole A, et al. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small, 2005, 1: 325\u2013327","journal-title":"Small"},{"key":"9244_CR65","volume-title":"Biomaterials","author":"C Peng","year":"2012","unstructured":"Peng C, Zheng L, Chen Q, et al. PEGylated dendrimer-entrapped gold nanoparticles for in vivo blood pool and tumor imaging by computed tomography. Biomaterials, 2012y, 33: 1107\u20131119"},{"key":"9244_CR66","doi-asserted-by":"publisher","first-page":"4412","DOI":"10.1039\/c3py00521f","volume":"4","author":"C Peng","year":"2013","unstructured":"Peng C, Qin J, Zhou B, et al. Targeted tumor CT imaging using folic acid-modified PEGylated dendrimer-entrapped gold nanoparticles. Polym Chem, 2013, 4: 4412\u20134424","journal-title":"Polym Chem"},{"key":"9244_CR67","doi-asserted-by":"publisher","first-page":"6944","DOI":"10.1021\/am500761x","volume":"6","author":"H Liu","year":"2014","unstructured":"Liu H, Wang H, Xu Y, et al. Lactobionic acid-modified dendrimerentrapped gold nanoparticles for targeted computed tomography imaging of human hepatocellular carcinoma. ACS Appl Mater Interfaces, 2014, 6: 6944\u20136953","journal-title":"ACS Appl Mater Interfaces"},{"key":"9244_CR68","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1039\/C4TB01542H","volume":"3","author":"Y Cao","year":"2015","unstructured":"Cao Y, He Y, Liu H, et al. Targeted CT imaging of human hepatocellular carcinoma using low-generation dendrimer-entrapped gold nanoparticles modified with lactobionic acid. J Mater Chem B, 2015, 3: 286\u2013295","journal-title":"J Mater Chem B"},{"key":"9244_CR69","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.1039\/C3NR06694K","volume":"6","author":"H Liu","year":"2014","unstructured":"Liu H, Wang H, Xu Y, et al. Synthesis of PEGylated low generation dendrimer-entrapped gold nanoparticles for CT imaging applications. Nanoscale, 2014, 6: 4521\u20134526","journal-title":"Nanoscale"},{"key":"9244_CR70","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1039\/c2py20993d","volume":"4","author":"H Liu","year":"2013","unstructured":"Liu H, Xu Y, Wen S, et al. Facile hydrothermal synthesis of low generation dendrimer-stabilized gold nanoparticles for in vivo computed tomography imaging applications. Polym Chem, 2013, 4: 1788\u20131795","journal-title":"Polym Chem"},{"key":"9244_CR71","doi-asserted-by":"publisher","first-page":"6409","DOI":"10.1002\/chem.201204612","volume":"19","author":"H Liu","year":"2013","unstructured":"Liu H, Xu Y, Wen S, et al. Targeted tumor computed tomography imaging using low-generation dendrimer-stabilized gold nanoparticles. Chem Eur J, 2013, 19: 6409\u20136416","journal-title":"Chem Eur J"},{"key":"9244_CR72","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1039\/c0jm04094k","volume":"21","author":"R Guo","year":"2011","unstructured":"Guo R, Wang H, Peng C, et al. Enhanced X-ray attenuation property of dendrimer-entrapped gold nanoparticles complexed with diatrizoic acid. J Mater Chem, 2011, 21: 5120\u20135127","journal-title":"J Mater Chem"},{"key":"9244_CR73","doi-asserted-by":"publisher","first-page":"6768","DOI":"10.1039\/c2nr31687k","volume":"4","author":"C Peng","year":"2012","unstructured":"Peng C, Li K, Cao X, et al. Facile formation of dendrimer-stabilized gold nanoparticles modified with diatrizoic acid for enhanced computed tomography imaging applications. Nanoscale, 2012, 4: 6768\u20136778","journal-title":"Nanoscale"},{"key":"9244_CR74","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1158\/1535-7163.MCT-05-0161","volume":"4","author":"MV Backer","year":"2005","unstructured":"Backer MV, Gaynutdinov TI, Patel V, et al. Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature. Mol Cancer Ther, 2005, 4: 1423\u20131429","journal-title":"Mol Cancer Ther"},{"key":"9244_CR75","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1073\/pnas.0910261107","volume":"107","author":"QT Nguyen","year":"2010","unstructured":"Nguyen QT, Olson ES, Aguilera TA, et al. Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival. Proc Natl Acad Sci USA, 2010, 107: 4317\u20134322","journal-title":"Proc Natl Acad Sci USA"},{"key":"9244_CR76","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1039\/C4NR06050D","volume":"7","author":"O Taratula","year":"2015","unstructured":"Taratula O, Schumann C, Duong T, et al. Dendrimer-encapsulated naphthalocyanine as a single agent-based theranostic nanoplatform for near-infrared fluorescence imaging and combinatorial anticancer phototherapy. Nanoscale, 2015, 7: 3888\u20133902","journal-title":"Nanoscale"},{"key":"9244_CR77","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.1021\/mp400397t","volume":"10","author":"O Taratula","year":"2013","unstructured":"Taratula O, Schumann C, Naleway MA, et al. A multifunctional theranostic platform based on phthalocyanine-loaded dendrimer for image-guided drug delivery and photodynamic therapy. Mol Pharm, 2013, 10: 3946\u20133958","journal-title":"Mol Pharm"},{"key":"9244_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-014-0033-9","volume":"12","author":"M Morales-Cruz","year":"2014","unstructured":"Morales-Cruz M, Figueroa CM, Gonz\u00e1lez-Robles T, et al. Activation of caspase-dependent apoptosis by intracellular delivery of cytochrome c-based nanoparticles. J Nanobiotechnol, 2014, 12: 1\u201311","journal-title":"J Nanobiotechnol"},{"key":"9244_CR79","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1021\/mp100043h","volume":"7","author":"S Santra","year":"2010","unstructured":"Santra S, Kaittanis C, Perez JM. Cytochrome c encapsulating theranostic nanoparticles: a novel bifunctional system for targeted delivery of therapeutic membrane-impermeable proteins to tumors and imaging of cancer therapy. Mol Pharm, 2010, 7: 1209\u20131222","journal-title":"Mol Pharm"},{"key":"9244_CR80","doi-asserted-by":"publisher","first-page":"9270","DOI":"10.1002\/chem.200901597","volume":"15","author":"AM Caminade","year":"2009","unstructured":"Caminade AM, Hameau A\u00c3, Majoral JP. Multicharged and\/or water-soluble fluorescent dendrimers: properties and uses. Chem Eur J, 2009, 15: 9270\u20139285","journal-title":"Chem Eur J"},{"key":"9244_CR81","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1002\/anie.200604651","volume":"46","author":"L Griffe","year":"2007","unstructured":"Griffe L, Poupot M, Marchand P, et al. Multiplication of human natural killer cells by nanosized phosphonate-capped dendrimers. Angew Chem Int Ed, 2007, 46: 2523\u20132526","journal-title":"Angew Chem Int Ed"},{"key":"9244_CR82","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1096\/fj.06-5742com","volume":"20","author":"M Poupot","year":"2006","unstructured":"Poupot M, Griffe L, Marchand P, et al. Design of phosphorylated dendritic architectures to promote human monocyte activation. FASEB J, 2006, 20: 2339\u20132351","journal-title":"FASEB J"},{"key":"9244_CR83","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1126\/scitranslmed.3002212","volume":"3","author":"M Hayder","year":"2011","unstructured":"Hayder M, Poupot M, Baron M, et al. A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis. Sci Translational Med, 2011, 3: 81ra35\u201381ra35","journal-title":"Sci Translational Med"},{"key":"9244_CR84","doi-asserted-by":"publisher","first-page":"7722","DOI":"10.1038\/ncomms8722","volume":"6","author":"AM Caminade","year":"2015","unstructured":"Caminade AM, Fruchon S, Turrin CO, et al. The key role of the scaffold on the efficiency of dendrimer nanodrugs. Nat Commun, 2015, 6: 7722","journal-title":"Nat Commun"},{"key":"9244_CR85","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1016\/j.nano.2016.07.009","volume":"12","author":"M Poupot","year":"2016","unstructured":"Poupot M, Turrin CO, Caminade AM, et al. Poly(phosphorhydrazone) dendrimers: yin and yang of monocyte activation for human NK cell amplification applied to immunotherapy against multiple myeloma. NanoMed-Nanotechnol Biol Med, 2016, 12: 2321\u20132330","journal-title":"NanoMed-Nanotechnol Biol Med"},{"key":"9244_CR86","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1021\/mp4000184","volume":"10","author":"N Brahmi El","year":"2013","unstructured":"El Brahmi N, El Kazzouli S, Mignani SM, et al. Original multivalent copper(II)-conjugated phosphorus dendrimers and corresponding mononuclear copper(II) complexes with antitumoral activities. Mol Pharm, 2013, 10: 1459\u20131464","journal-title":"Mol Pharm"},{"key":"9244_CR87","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ejmech.2017.03.035","volume":"132","author":"S Mignani","year":"2017","unstructured":"Mignani S, El Brahmi N, Eloy L, et al. Anticancer copper(II) phosphorus dendrimers are potent proapoptotic Bax activators. Eur J Medicinal Chem, 2017, 132: 142\u2013156","journal-title":"Eur J Medicinal Chem"},{"key":"9244_CR88","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1002\/adhm.201600923","volume":"5","author":"P Wei","year":"2016","unstructured":"Wei P, Chen J, Hu Y, et al. Dendrimer-stabilized gold nanostars as a multifunctional theranostic nanoplatform for CT imaging, photothermal therapy, and gene silencing of tumors. Adv Healthcare Mater, 2016, 5: 3203\u20133213","journal-title":"Adv Healthcare Mater"},{"key":"9244_CR89","doi-asserted-by":"publisher","first-page":"15995","DOI":"10.1021\/acsami.7b03371","volume":"9","author":"L Kong","year":"2017","unstructured":"Kong L, Xing L, Zhou B, et al. Dendrimer-modified MoS2 nanoflakes as a platform for combinational gene silencing and photothermal therapy of tumors. ACS Appl Mater Interfaces, 2017, 9: 15995\u201316005","journal-title":"ACS Appl Mater Interfaces"},{"key":"9244_CR90","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1590\/S1984-82502013000700001","volume":"49","author":"JG Vargas","year":"2013","unstructured":"Vargas JG. Dendrimers: from the art of building precise molecules to the dissemination through the world. Braz J Pharm Sci, 2013, 49: 4\u20135","journal-title":"Braz J Pharm Sci"},{"key":"9244_CR91","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3109\/10837450.2013.862264","volume":"20","author":"RS Kalhapure","year":"2015","unstructured":"Kalhapure RS, Kathiravan MK, Akamanchi KG, et al. Dendrimers \u2014from organic synthesis to pharmaceutical applications: an update. Pharmaceutical Dev Tech, 2015, 20: 22\u201340","journal-title":"Pharmaceutical Dev Tech"},{"key":"9244_CR92","volume-title":"Adv Drug Deliver Rev","author":"S Mignani","year":"2017","unstructured":"Mignani S, Rodrigues J, Tomas H, et al. Bench-to-bedside translation of dendrimers: Reality or utopia? A concise analysis. Adv Drug Deliver Rev, 2017, 10.1016\/j.addr.2017.11.007"},{"key":"9244_CR93","first-page":"993","volume":"38","author":"S Mignani","year":"2013","unstructured":"Mignani S, Kazzouli SE, Bousmina M, et al. Dendrimer space concept for innovative nanomedicine: A futuristic vision for medicinal chemistry. Prog Polymer Sci, 2013, 38: 993\u20131008","journal-title":"Dendrimer space concept for innovative nanomedicine: A futuristic vision for medicinal chemistry. Prog Polymer Sci"},{"key":"9244_CR94","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1021\/bc5006224","volume":"26","author":"V Leiro","year":"2015","unstructured":"Leiro V, Garcia JP, Tom\u00e1s H, et al. The present and the future of degradable dendrimers and derivatives in theranostics. Bioconjugate Chem, 2015, 26: 1182\u20131197","journal-title":"Bioconjugate Chem"},{"key":"9244_CR95","volume-title":"CPD","author":"RFR Alberto","year":"2017","unstructured":"Alberto RFR, Joao R, de Los Angeles MFM, et al. Principal physicochemical methods used to characterize dendrimer molecule complexes used as genetic therapy agents, nanovaccines or drug carriers. CPD, 2017, 23"},{"key":"9244_CR96","doi-asserted-by":"publisher","first-page":"150","DOI":"10.7150\/thno.9476","volume":"5","author":"SK Patel","year":"2015","unstructured":"Patel SK, Janjic JM. Macrophage targeted theranostics as personalized nanomedicine strategies for inflammatory diseases. Theranostics, 2015, 5: 150\u2013172","journal-title":"Theranostics"}],"container-title":["Science China Materials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40843-018-9244-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40843-018-9244-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40843-018-9244-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,7]],"date-time":"2019-04-07T23:06:21Z","timestamp":1554678381000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40843-018-9244-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,8]]},"references-count":96,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["9244"],"URL":"https:\/\/doi.org\/10.1007\/s40843-018-9244-5","relation":{},"ISSN":["2095-8226","2199-4501"],"issn-type":[{"value":"2095-8226","type":"print"},{"value":"2199-4501","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,8]]},"assertion":[{"value":"19 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}